Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19

Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kachestvennai͡a︡ klinicheskai͡a︡ praktika 2020-10 (4S), p.18-22
Hauptverfasser: Otdelenov, V. A., Mirzaev, K. B., Sychev, D. A.
Format: Artikel
Sprache:eng
Schlagworte:
covid-19
коронавирус
прямые пероральные антикоагулянты
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions.
ISSN:2588-0519
2618-8473
DOI:10.37489/2588-0519-2020-S4-18-22